iBio, Inc. Income Statement
IBIO|13 years of annual SEC 10-K data (FY2013-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 13 fiscal years. All figures from audited SEC 10-K filings.
iBio, Inc. reported $225,000 in revenue and $25M in net loss for FY2025. Revenue has declined at a 13.5% compound annual rate over the past 12 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $225.0K | $0 | $1.9M | $2.4M | $1.6M | $2.0M | $444.0K | $394.0K | $948.0K | $1.9M | $205.0K | $1.0M | $1.3M |
| Cost of Revenue | - | - | - | $1.5M | $703.0K | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | $909.0K | $935.0K | - | - | - | - | - | - | - | - |
| SG&A Expense | $11.7M | $19.0M | $21.8M | $22.0M | $11.4M | $12.3M | $10.7M | $10.6M | $7.7M | $5.0M | $3.9M | $4.2M | $5.6M |
| R&D Expense | $5.2M | $10.3M | $9.8M | $10.0M | $3.6M | $5.5M | $4.0M | $4.1M | $3.2M | $3.5M | $1.9M | $3.4M | $5.0M |
| Operating Income | -$16.6M | -$29.3M | -$29.7M | -$31.1M | -$14.0M | -$15.8M | -$14.2M | -$14.3M | -$9.9M | -$6.7M | -$3.8M | -$6.7M | -$9.3M |
| Interest Expense | - | - | $83.0K | $2.5M | $2.5M | $1.9M | $1.9M | $1.9M | $807.0K | $0 | - | $90.0K | $63.0K |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$24.9M | -$65.0M | -$50.3M | -$23.2M | -$16.4M | -$17.6M | -$16.1M | -$14.5M | -$9.8M | -$6.6M | -$3.7M | -$6.2M | -$5.7M |
| EPS (Basic) | -$6.50 | -$106.19 | -$5.78 | -$3.00 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$6.50 | -$106.19 | -$5.78 | -$3.00 | -$0.61 | -$0.94 | -$1.54 | -$1.64 | -$0.12 | -$0.09 | -$0.06 | -$0.13 | -$0.14 |
| Shares Outstanding | 8.6M | 1.0M | 8.7M | 8.7M | 140.1M | 20.2M | 16.0M | 8.9M | 89.1M | 77.2M | 65.6M | 56.7M | 47.8M |
| Gross Margin | - | - | - | 38.3% | 57.1% | - | - | - | - | - | - | - | - |
| Operating Margin | -7392.9% | - | -1576.3% | -1312.1% | -854.9% | -782.4% | -3204.3% | -3622.8% | -1043.6% | -360.1% | -1873.2% | -662.1% | -730.4% |
| Profit Margin | -11069.8% | - | -2670.1% | -978.8% | -1003.6% | -871.8% | -3627.3% | -3688.3% | -1030.0% | -357.9% | -1788.3% | -615.5% | -444.5% |